Beth Seidenberg

Board Member

Equibles does not estimate personal net worth.

Get an email with a short summary when Kyverna Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get KYTX alerts

About Beth Seidenberg

Beth Seidenberg is recorded as Board Member at Kyverna Therapeutics, Inc. (KYTX) since January 1, 2018 and Board Member at Vera Therapeutics, Inc. (VERA) since January 1, 2016. The newest filing on record that lists Beth Seidenberg as Board Member at Kyverna Therapeutics, Inc. (KYTX) is dated April 13, 2026. The newest filing on record that lists Beth Seidenberg as Board Member at Vera Therapeutics, Inc. (VERA) is dated April 9, 2026. Beth Seidenberg was last confirmed as Board Member at Sagimet Biosciences Inc. (SGMT) in a filing dated April 30, 2025. Beth Seidenberg was last confirmed as Board Member at Progyny, Inc. (PGNY) in a filing dated April 12, 2024. Kyverna Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Vera Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Kyverna Therapeutics, Inc. includes Warner Biddle (CEO and Board Member), Christi Shaw (Chairman and Board Member), Greg Martini (CFO) and 7 others.

Affiliation history

Kyverna Therapeutics, Inc. (KYTX)
Board Member

Proxy statement

Current
2018-01-01–present

Last confirmed April 13, 2026
Vera Therapeutics, Inc. (VERA)
Board Member

Proxy statement

Current
2016-01-01–present

Last confirmed April 9, 2026
Sagimet Biosciences Inc. (SGMT)
Board Member

Proxy statement

Start not stated–2025-04-30

Last confirmed by a filing; no departure on record
Progyny, Inc. (PGNY)
Board Member

Proxy statement

Start not stated–2024-04-12

Last confirmed by a filing; no departure on record
Progyny, Inc. (PGNY)
Proxy statement

Start not stated–2021-04-22

Last confirmed by a filing; no departure on record